21 CFR 1302.01 - Scope of part 1302

Cite as21 CFR 1302.01
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
1 practice notes
  • Top RX Pharmacy; Decision and Order
    • United States
    • Federal Register May 03, 2013
    • May 3, 2013
    ...constituted a violation of DEA regulations. --------------------------------------------------------------------------- \72\ See 21 C.F.R. Sec. 1302.01 (``Requirements governing the labeling and packaging of controlled substances pursuant to sections 1305 and 1008(d) of the Act (21 U.S.C. 8......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT